Shuttle Pharmaceuticals Holdings (SHPH) Gains from Investment Securities (2021 - 2025)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Gains from Investment Securities of $231720.0 in Q4 2025, little changed quarter-over-quarter from $231720.0 in Q3 2025, and up 423.78% on a YoY basis from $44240.3 in Q4 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Gains from Investment Securities (2021 - 2025) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $231720.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 423.78% year-over-year to $231720.0; the TTM figure through Dec 2025 stood at $231720.0 (up 711.63% YoY), while the FY2025 annual figure was $231720.0, down 80.27% from the prior year.
- Gains from Investment Securities was $231720.0 for Q4 2025 at Shuttle Pharmaceuticals Holdings, roughly flat from $231720.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $552486.0 in Q1 2025 to a low of -$71568.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged $163250.2 across 5 years, with a median of $62732.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities tumbled 2318.47% in 2024, then jumped 13585.56% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $365926.0 in 2021, then jumped by 34.64% to $492700.0 in 2022, then sank by 99.35% to $3226.0 in 2023, then sank by 2318.47% to -$71568.0 in 2024, then jumped by 423.78% to $231720.0 in 2025.
- The last three Gains from Investment Securities figures came in at $231720.0 (Q4 2025), $231720.0 (Q3 2025), and $69066.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.43 Mn | 1.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 231,720.00 |
| Dec 31, 2025 | 231,720.00 |
| Sep 30, 2025 | 231,720.00 |
| Sep 30, 2025 | 231,720.00 |
| Jun 30, 2025 | 69,066.00 |
| Jun 30, 2025 | 69,066.00 |
| Mar 31, 2025 | 552,486.00 |
| Mar 31, 2025 | 552,486.00 |
| Dec 31, 2024 | -71,568.00 |
| Dec 31, 2024 | -71,568.00 |
| Sep 30, 2024 | 56,398.00 |
| Sep 30, 2024 | 56,398.00 |
| Jun 30, 2024 | 39,683.00 |
| Jun 30, 2024 | 39,683.00 |
| Mar 31, 2024 | 4,037.00 |
| Mar 31, 2024 | 4,037.00 |
| Dec 31, 2023 | 3,226.00 |
| Dec 31, 2023 | 3,226.00 |
| Sep 30, 2023 | 159,326.00 |
| Sep 30, 2023 | 159,326.00 |